C

CMG제약

058820KOSDAQ의약품 제조업

46.0 / 100

Reference Date: 2026-07-24

Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CMG Pharmaceutical is a core subsidiary of Chabiotech Group, specializing in the R&D, production, and sales of pharmaceuticals and health functional foods. The company focuses on developing improved new drugs using its proprietary STARFILM Technology, which enables unique taste and stability in oral disintegrating films (ODF). It is expanding into high-growth sectors such as oncology, anti-aging, ophthalmology, and maternal and baby care, while also operating an animal pharmaceutical business through its subsidiaries to enhance shareholder value.

Number of Employees

206people

Average Salary

62.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 11.234.0Point
PBR
0.58Industry Average 0.815.5Point

Lower than industry avg (good)

ROE
-5.15Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
0.37Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.9% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼264.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -0.1% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 795Won52-week high 2,14052-week low 785
1-month return1.0Point

1m -14.61% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0
  • Neutral주주명부폐쇄기간또는기준일설정2026-07-22
  • Neutral주식병합결정2026-07-22
  • Neutral주주총회소집결의 (임시주주총회)2026-07-22
  • Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-07-13
  • Neutral주식등의대량보유상황보고서(약식)2026-07-07